Lisa Safaah Novia Larsiani, D. Tamtomo, Bhisma Murti
{"title":"高血压、吸烟与COVID-19严重程度风险相关性的meta分析","authors":"Lisa Safaah Novia Larsiani, D. Tamtomo, Bhisma Murti","doi":"10.26911/jepublichealth.2022.07.03.04","DOIUrl":null,"url":null,"abstract":"Background: Based on the reported cases, 16.9% of COVID-19 patients were accompanied by comorbidities. Hypertension and smoking are suspected to be one of the pathological determinants that play a role in clinical predictors that are predicted to cause a worsening of the patient's condition during the treatment period. This study aimed to examine correlations between hypertension, smoking, and severity risk of COVID-19. Subjects and Method: Meta-analysis was carried out using PRISMA flow diagrams. Article searches through journal databases include: PubMed, Science Direct, Google Scholar. articles used in 2020-2022. The PICOs in this study were, Population: COVID-19 patients, Intervention: hypertension and smoking Comparation: not hypertension and not smoking, Outcome: severity of COVID-19. The keywords in this study were \"hypertention\" OR \"high blood pressure\" AND \"severe COVID-19\" OR \"severty COVID-19\" OR \"patient COVID-19 outcome\" \"cigarette\" OR \"smoking\" OR \"current smoker\" OR former smoker\" AND \"severe COVID-19\" OR \"severty COVID-19\" OR \"patient COVID-19 outcome\" Inclusion criteria were articles used in full paper articles with a cohort design, relationship size used with aOR, intervention given the association of hypertension and smoking on the severity of COVID-19. Eligible articles were analyzed using the Revman 5.3 application.","PeriodicalId":91740,"journal":{"name":"Journal of epidemiology and public health reviews","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Meta-Analysis Correlations between Hypertension, Smoking, and Severity Risk of COVID-19\",\"authors\":\"Lisa Safaah Novia Larsiani, D. Tamtomo, Bhisma Murti\",\"doi\":\"10.26911/jepublichealth.2022.07.03.04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Based on the reported cases, 16.9% of COVID-19 patients were accompanied by comorbidities. Hypertension and smoking are suspected to be one of the pathological determinants that play a role in clinical predictors that are predicted to cause a worsening of the patient's condition during the treatment period. This study aimed to examine correlations between hypertension, smoking, and severity risk of COVID-19. Subjects and Method: Meta-analysis was carried out using PRISMA flow diagrams. Article searches through journal databases include: PubMed, Science Direct, Google Scholar. articles used in 2020-2022. The PICOs in this study were, Population: COVID-19 patients, Intervention: hypertension and smoking Comparation: not hypertension and not smoking, Outcome: severity of COVID-19. The keywords in this study were \\\"hypertention\\\" OR \\\"high blood pressure\\\" AND \\\"severe COVID-19\\\" OR \\\"severty COVID-19\\\" OR \\\"patient COVID-19 outcome\\\" \\\"cigarette\\\" OR \\\"smoking\\\" OR \\\"current smoker\\\" OR former smoker\\\" AND \\\"severe COVID-19\\\" OR \\\"severty COVID-19\\\" OR \\\"patient COVID-19 outcome\\\" Inclusion criteria were articles used in full paper articles with a cohort design, relationship size used with aOR, intervention given the association of hypertension and smoking on the severity of COVID-19. Eligible articles were analyzed using the Revman 5.3 application.\",\"PeriodicalId\":91740,\"journal\":{\"name\":\"Journal of epidemiology and public health reviews\",\"volume\":\"35 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of epidemiology and public health reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26911/jepublichealth.2022.07.03.04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of epidemiology and public health reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26911/jepublichealth.2022.07.03.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Meta-Analysis Correlations between Hypertension, Smoking, and Severity Risk of COVID-19
Background: Based on the reported cases, 16.9% of COVID-19 patients were accompanied by comorbidities. Hypertension and smoking are suspected to be one of the pathological determinants that play a role in clinical predictors that are predicted to cause a worsening of the patient's condition during the treatment period. This study aimed to examine correlations between hypertension, smoking, and severity risk of COVID-19. Subjects and Method: Meta-analysis was carried out using PRISMA flow diagrams. Article searches through journal databases include: PubMed, Science Direct, Google Scholar. articles used in 2020-2022. The PICOs in this study were, Population: COVID-19 patients, Intervention: hypertension and smoking Comparation: not hypertension and not smoking, Outcome: severity of COVID-19. The keywords in this study were "hypertention" OR "high blood pressure" AND "severe COVID-19" OR "severty COVID-19" OR "patient COVID-19 outcome" "cigarette" OR "smoking" OR "current smoker" OR former smoker" AND "severe COVID-19" OR "severty COVID-19" OR "patient COVID-19 outcome" Inclusion criteria were articles used in full paper articles with a cohort design, relationship size used with aOR, intervention given the association of hypertension and smoking on the severity of COVID-19. Eligible articles were analyzed using the Revman 5.3 application.